Amarantus Bioscience Holdings Stock Price To Earning
| AMBS Stock | USD 0.0001 0.00 0.00% |
Amarantus Bioscience Holdings fundamentals help investors to digest information that contributes to Amarantus Bioscience's financial success or failures. It also enables traders to predict the movement of Amarantus Pink Sheet. The fundamental analysis module provides a way to measure Amarantus Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amarantus Bioscience pink sheet.
Amarantus |
Amarantus Bioscience Holdings Company Price To Earning Analysis
Amarantus Bioscience's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Amarantus Bioscience Price To Earning | (0.01) X |
Most of Amarantus Bioscience's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amarantus Bioscience Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Amarantus Bioscience Holdings has a Price To Earning of -0.01 times. This is 100.04% lower than that of the Biotechnology sector and 100.2% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.03% higher than that of the company.
Amarantus Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amarantus Bioscience's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amarantus Bioscience could also be used in its relative valuation, which is a method of valuing Amarantus Bioscience by comparing valuation metrics of similar companies.Amarantus Bioscience is currently under evaluation in price to earning category among its peers.
Amarantus Fundamentals
| Current Valuation | 6.59 M | |||
| Shares Outstanding | 68.27 M | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 53.19 X | |||
| EBITDA | (20.79 M) | |||
| Net Income | (10.58 M) | |||
| Cash And Equivalents | 178 | |||
| Total Debt | 20.72 M | |||
| Debt To Equity | 0.84 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 9.0 | |||
| Number Of Employees | 19 | |||
| Beta | 1.67 | |||
| Market Capitalization | 3.13 M | |||
| Total Asset | 3.48 M | |||
| Retained Earnings | (104.87 M) | |||
| Working Capital | (14.89 M) | |||
| Current Asset | 942 K | |||
| Current Liabilities | 15.83 M | |||
| Z Score | -63.3 | |||
| Net Asset | 3.48 M |
About Amarantus Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amarantus Bioscience Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amarantus Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amarantus Bioscience Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.